Europe Cancer Biomarkers Market Size, Share & Industry Trends Analysis Report By Profiling Technologies, By Application, By Type, By Cancer Type, By Country and Growth Forecast, 2022 - 2028

The Europe Cancer Biomarkers Market would witness Market growth of 16.1% CAGR during the forecast period (2022-2028).

As data is generated more actively in the healthcare industry, a few emerging countries have transcended the shortage of data, and the rest countries are likely to follow suit. This data supplementation is expected to serve as the foundation for any national cancer policy. As a result, this factor may contribute to a growth in the number of patients seeking cancer treatment. As a result, the cancer biomarkers Market is expected to grow as demand grows in low- and middle-income nations.

Growing initiatives to create medications that target novel cancer biomarkers, as well as the launch of the technologically sophisticated companion diagnostic kits, are expected to propel the Market forward. The usage of cancer biomarkers is expected to increase as patients become more aware of tailored therapies. The Global Cancer Biomarkers Market study offers a comprehensive analysis of the industry. The research includes a detailed analysis of key trends, segments, drivers, constraints, the competitive landscape, and other important Market variables.

According to 2015 data, the United Kingdom's Department of Health and Social Care invests significantly yearly in cancer-related treatment and services. Biomarkers can be used to assess patients in a variety of clinical settings, including estimating disease risk, screening for occult primary cancers, differentiating benign from malignant findings or one type of malignancy from another, identifying prognosis and prediction for cancer patients, and monitoring disease status, either to detect recurrence or ascertain response or progression to therapy. Lung cancer is caused by the uncontrollable proliferation of aberrant cells in one or both lungs. Persons who smoke have the biggest risk of lung cancer, despite the fact that it can affect people who have never smoked. The time and number of cigarettes smoked by a patient increase the risk of lung cancer. Other risk factors include asbestos, second-hand smoke, certain metals, some organic compounds, radiation, air pollution, and diesel exhaust at the workplace or in the environment.

The Germany Market dominated the Europe Cancer Biomarkers Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $2,234.1 million by 2028. The UK Market is anticipated to grow at a CAGR of 15.1% during (2022 - 2028). Additionally, The France Market would witness a CAGR of 17% during (2022 - 2028).

Based on Profiling Technologies, the Market is segmented into Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, and Cytogenetics. Based on Application, the Market is segmented into Diagnostics, Research & Development, Prognostics, Risk Assessment, and Others. Based on Type, the Market is segmented into Protein, Genetic, and Others. Based on Cancer Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Thyroid Cancer, Melanoma & Leukemia, Kidney & Bladder Cancer, Non-Hodgkin's Lymphoma, Prostate Cancer, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Cancer Biomarkers Market Size will Hit $34.3 Billion by 2028, at a CAGR of 16.8%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Agilent Technologies, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments Covered in the Report:

By Profiling Technologies

• Omics Technologies
• Imaging Technologies
• Immunoassay
• Bioinformatics
• Cytogenetics

By Application

• Diagnostics
• Research & Development
• Prognostics
• Risk Assessment
• Others

By Type

• Protein
• Genetic
• Others

By Cancer Type

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Thyroid Cancer
• Melanoma & Leukemia
• Kidney & Bladder Cancer
• Non-Hodgkin's Lymphoma
• Prostate Cancer
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Agilent Technologies, Inc.
• Merck & Co., Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cancer Biomarkers Market, by Profiling Technologies
1.4.2 Europe Cancer Biomarkers Market, by Application
1.4.3 Europe Cancer Biomarkers Market, by Type
1.4.4 Europe Cancer Biomarkers Market, by Cancer Type
1.4.5 Europe Cancer Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Cancer Biomarkers Market

Chapter 4. Europe Cancer Biomarkers Market by Profiling Technologies
4.1 Europe Omics Technologies Market by Country
4.2 Europe Imaging Technologies Market by Country
4.3 Europe Immunoassay Market by Country
4.4 Europe Bioinformatics Market by Country
4.5 Europe Cytogenetics Market by Country

Chapter 5. Europe Cancer Biomarkers Market by Application
5.1 Europe Diagnostics Market by Country
5.2 Europe Research & Development Market by Country
5.3 Europe Prognostics Market by Country
5.4 Europe Risk Assessment Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe Cancer Biomarkers Market by Type
6.1 Europe Protein Market by Country
6.2 Europe Genetic Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Cancer Biomarkers Market by Cancer Type
7.1 Europe Breast Cancer Market by Country
7.2 Europe Lung Cancer Market by Country
7.3 Europe Colorectal Cancer Market by Country
7.4 Europe Thyroid Cancer Market by Country
7.5 Europe Melanoma & Leukemia Market by Country
7.6 Europe Kidney & Bladder Cancer Market by Country
7.7 Europe Non-Hodgkin's Lymphoma Market by Country
7.8 Europe Prostate Cancer Market by Country
7.9 Europe Others Market by Country

Chapter 8. Europe Cancer Biomarkers Market by Country
8.1 Germany Cancer Biomarkers Market
8.1.1 Germany Cancer Biomarkers Market by Profiling Technologies
8.1.2 Germany Cancer Biomarkers Market by Application
8.1.3 Germany Cancer Biomarkers Market by Type
8.1.4 Germany Cancer Biomarkers Market by Cancer Type
8.2 UK Cancer Biomarkers Market
8.2.1 UK Cancer Biomarkers Market by Profiling Technologies
8.2.2 UK Cancer Biomarkers Market by Application
8.2.3 UK Cancer Biomarkers Market by Type
8.2.4 UK Cancer Biomarkers Market by Cancer Type
8.3 France Cancer Biomarkers Market
8.3.1 France Cancer Biomarkers Market by Profiling Technologies
8.3.2 France Cancer Biomarkers Market by Application
8.3.3 France Cancer Biomarkers Market by Type
8.3.4 France Cancer Biomarkers Market by Cancer Type
8.4 Russia Cancer Biomarkers Market
8.4.1 Russia Cancer Biomarkers Market by Profiling Technologies
8.4.2 Russia Cancer Biomarkers Market by Application
8.4.3 Russia Cancer Biomarkers Market by Type
8.4.4 Russia Cancer Biomarkers Market by Cancer Type
8.5 Spain Cancer Biomarkers Market
8.5.1 Spain Cancer Biomarkers Market by Profiling Technologies
8.5.2 Spain Cancer Biomarkers Market by Application
8.5.3 Spain Cancer Biomarkers Market by Type
8.5.4 Spain Cancer Biomarkers Market by Cancer Type
8.6 Italy Cancer Biomarkers Market
8.6.1 Italy Cancer Biomarkers Market by Profiling Technologies
8.6.2 Italy Cancer Biomarkers Market by Application
8.6.3 Italy Cancer Biomarkers Market by Type
8.6.4 Italy Cancer Biomarkers Market by Cancer Type
8.7 Rest of Europe Cancer Biomarkers Market
8.7.1 Rest of Europe Cancer Biomarkers Market by Profiling Technologies
8.7.2 Rest of Europe Cancer Biomarkers Market by Application
8.7.3 Rest of Europe Cancer Biomarkers Market by Type
8.7.4 Rest of Europe Cancer Biomarkers Market by Cancer Type

Chapter 9. Company Profiles
9.1 BioMérieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Qiagen N.V.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Product Launches and Product Expansions:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Merck & Co., Inc. (Merck Millipore)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses

TABLE 1 Europe Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 Europe Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Europe Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 4 Europe Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 5 Europe Omics Technologies Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Omics Technologies Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Imaging Technologies Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Imaging Technologies Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Bioinformatics Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Bioinformatics Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Cytogenetics Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Cytogenetics Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 16 Europe Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 17 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Research & Development Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Research & Development Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Prognostics Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Prognostics Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Risk Assessment Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Risk Assessment Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 28 Europe Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 29 Europe Protein Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Protein Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Genetic Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Genetic Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 36 Europe Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 37 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Colorectal Cancer Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Colorectal Cancer Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Thyroid Cancer Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Thyroid Cancer Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 49 Europe Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 50 Europe Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 51 Europe Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 52 Europe Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 53 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 54 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 55 Europe Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 56 Europe Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 57 Germany Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 Germany Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 Germany Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 60 Germany Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 61 Germany Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 Germany Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 Germany Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 64 Germany Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 65 Germany Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 66 Germany Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 67 UK Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 68 UK Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 69 UK Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 70 UK Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 71 UK Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 72 UK Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 73 UK Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 74 UK Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 75 UK Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 76 UK Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 77 France Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 78 France Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 79 France Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 80 France Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 81 France Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 France Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 France Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 84 France Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 85 France Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 86 France Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 87 Russia Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 88 Russia Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 89 Russia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 90 Russia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 91 Russia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 92 Russia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 93 Russia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 Russia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 Russia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 96 Russia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 97 Spain Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 98 Spain Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 99 Spain Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 100 Spain Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 101 Spain Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 102 Spain Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 103 Spain Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 104 Spain Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 105 Spain Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 106 Spain Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 107 Italy Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 108 Italy Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 109 Italy Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 110 Italy Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 111 Italy Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 112 Italy Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 113 Italy Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 114 Italy Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 115 Italy Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 116 Italy Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 117 Rest of Europe Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 118 Rest of Europe Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 119 Rest of Europe Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 120 Rest of Europe Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 121 Rest of Europe Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 122 Rest of Europe Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 123 Rest of Europe Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 124 Rest of Europe Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 125 Rest of Europe Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 126 Rest of Europe Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 127 Key information – BioMérieux S.A.
TABLE 128 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 129 Key information – Becton, Dickinson and Company
TABLE 130 Key Information – Abbott Laboratories
TABLE 131 Key Information – Thermo Fisher Scientific, Inc.
TABLE 132 key information – Illumina, Inc.
TABLE 133 Key Information – Bio-Rad Laboratories, Inc.
TABLE 134 Key Information – Qiagen N.V.
TABLE 135 key Information – Agilent Technologies, Inc.
TABLE 136 KEY INFORMATION - MERCK & CO., INC.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 3 Swot analysis: thermo fisher scientific, inc.